The transgenic rat TGR(mRen2)27 is a new monogenetic model in hyperten
sion research that develops fulminant hypertension after the mouse Ren
-2(d) renin gene has been integrated into its genome. To evaluate the
molecular mechanism of development of hypertension in this animal mode
l, we measured cytosolic free sodium concentration in intact lymphocyt
es from seven transgenic rats and eight age-matched normotensive Sprag
ue-Dawley rats using the novel sodium-sensitive fluorescent dye sodium
-binding benzofuran-isophthalate. Resting cytosolic sodium was signifi
cantly higher in transgenic rats compared with Sprague-Dawley rats (31
.7+/-2.2 versus 18.2+/-0.4 mmol/L, mean+/-SEM, P<.001). Inhibition of
Na,K-ATPase by 0.5 mmol/L ouabain for 5 minutes significantly increase
d lymphocytic cytosolic sodium in Sprague-Dawley rats to 36.5+/-3.4 mm
ol/L (P<.001 compared with resting value), whereas no significant chan
ge could be observed in transgenic rats (35.4+/-0.6 mmol/L), indicatin
g that Na,K-ATPase is less responsive in transgenic rats. The Na,K-ATP
ase activity from erythrocytes was measured with an enzyme-linked assa
y. Na,K-ATPase activity was significantly reduced in transgenic rats c
ompared with Sprague-Dawley rats (4.0+/-0.3 versus 8.1+/-0.6 U/L, P<.0
01). We concluded that reduced Na,K-ATPase activity leads to elevated
cytosolic sodium in this model of genetic hypertension.